Form 13-F position report

LEAP THERAPEUTICS INC

Reported by FMR LLC

LPTX CUSIP 52187K101 Manager CIK 0000315066

Reported 0 shares, down 1,000 (100.0%) from the prior quarter.

Reported value -100.0%; share count -100.0% vs. the prior quarter.

Reduced
% of reported 13F value 0 This manager · Q2 2022
Shares 0 Quarter-end amount reported
Reported value $0 Fair value at quarter end
Consecutive quarters held 2 Through Q2 2022

Reported position value by quarter

Reported position value by quarter

Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.

Reported position value by quarter
Date Holding Value
2022-03-31 2000
2022-06-30 0

Quarterly position history

How this manager's reported quarter-end position changed over time.

2 quarters
Quarterly reported position history for LEAP THERAPEUTICS INC held by FMR LLC.
Quarter Activity Shares Change % of reported 13F Reported value Filed Source filing
Q2 2022 Reduced 0 -1,000 (-100.0%) 0 $0 2022-08-12
Q1 2022 New 1,000 +1,000 (0.0%) < 0.01% $2,000 2022-05-13
Five years are shown. A free account unlocks the complete reported history. Unlock full history

Who else reported the position

85 managers reported LEAP THERAPEUTICS INC for Q2 2022.

Managers reporting LEAP THERAPEUTICS INC in Q2 2022.
Manager Activity Shares Change % of reported 13F Reported value Tenure
PERCEPTIVE ADVISORS LLC Unchanged 7,951,448 0 0.29% $9,144,000 10 qtrs
Artal Group S A Unchanged 4,000,000 0 0.25% $4,600,000 10 qtrs
Rock Springs Capital Management LP Added 3,652,947 +57,500 0.12% $4,201,000 4 qtrs
VANGUARD GROUP INC Unchanged 3,256,331 0 < 0.01% $3,744,000 20 qtrs
M28 Capital Management LP Unchanged 2,664,400 0 3.43% $3,064,000 3 qtrs
683 Capital Management LLC Added 1,439,821 +529,046 0.12% $1,656,000 2 qtrs
PLATINUM INVESTMENT MANAGEMENT LTD Unchanged 1,327,952 0 0.06% $1,527,000 8 qtrs
TANG CAPITAL MANAGEMENT LLC Unchanged 1,250,000 0 0.22% $1,438,000 4 qtrs
BlackRock Inc Added 1,199,035 +847 < 0.01% $1,378,000 21 qtrs
MILLENNIUM MANAGEMENT LLC Reduced 1,175,530 -382,569 < 0.01% $1,352,000 9 qtrs
Premium adds each manager's conviction percentile across reporting peers.
Filing details and methodology As reported
Report period
June 30, 2022
Filed
August 12, 2022
Filing type
13F-HR
Position type
COM

Voting authority reported

No voting-authority amounts were reported for this position. Voting authority is not required for reported call options.

Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.